The Usefulness and Wellbeing of Tofacitinib in the Treatment of Alopecia Areata
October 2022
in “
Journal of Armed Forces Medical College, Bangladesh
”
Studysummary In this clinical trial, Tofacitinib effectively promoted hair regrowth in patients with alopecia areata, alopecia totalis, and alopecia universalis, with 75.6% experiencing no side effects, making it a promising treatment option according to the study.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on banglajol.info →